Palatable reconstitutable dry suspension of artemether for flexible pediatric dosing using cyclodextrin inclusion complexation

The present research was conducted to investigate the inclusion complexation of artemether (ARM) with beta-cyclodextrin (CD) with the aim of masking the bitterness along with improving the drug release and preparing a stable palatable formulation of ARM especially for pediatrics. A physical mixture and kneaded system were prepared to study the inclusion complexation. Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD) and scanning electron microscopy (SEM) were performed to identify the physicochemical interaction between drug and carrier, hence its effect on drug release. Reconstitutable dry suspension was evaluated for angle of repose, sedimentation characterization and pH. In vitro drug release studies for physical mixture and kneaded system were performed at pH, 1.2 and 6.8. Bitterness score was evaluated using gustatory sensation test. The FTIR, DSC and XRPD studies indicated inclusion complexation in physical mixture and kneaded system. In addition, physical mixture and kneaded system exhibited improved drug release at pH, 1.2 and 6.8. To formulate palatable reconstitutable dry suspension of ARM, the 1:20M physical mixture was selected based on bitterness score. Reconstitutable dry suspension prepared using physical mixture (DS4), showed complete bitter taste masking, good flowability and ease of redispersibility. Taste evaluation of reconstitutable dry suspension in human volunteers rated tasteless with a score of 0 to DS4 and 3 to DS5 (reconstitutable dry suspension prepared using pure ARM). This conclusively demonstrated a stable and palatable reconstitutable dry suspension of ARM using CD inclusion complexation for flexible pediatric dosing.

[1]  R. Mashru,et al.  Design and optimization of artemether microparticles for bitter taste masking , 2008, Acta pharmaceutica.

[2]  R. Mashru,et al.  Formulation and Evaluation of Taste Masked Oral Reconstitutable Suspension of Primaquine Phosphate , 2008, AAPS PharmSciTech.

[3]  R. Mashru,et al.  Effect of chitosan crosslinking on bitterness of artemether using response surface methodology , 2008, The Journal of pharmacy and pharmacology.

[4]  G. Becket,et al.  Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems , 2003, AAPS PharmSciTech.

[5]  J. Remon,et al.  Quinine sulphate pellets for flexible pediatric drug dosing: formulation development and evaluation of taste-masking efficiency using the electronic tongue. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  J. Mielcarek,et al.  Inclusion Complexes of Felodipine and Amlodipine with Methyl-β-cyclodextrin , 2006 .

[7]  J. Sirithunyalug,et al.  Development of Suspending Agent from Sodium Carboxymethyl Mungbean Starches , 2006, Drug development and industrial pharmacy.

[8]  L. Szente,et al.  Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  Yahui Zhang,et al.  Inclusion complex of trimethoprim with β-cyclodextrin , 2005 .

[10]  Yahui Zhang,et al.  Inclusion complex of trimethoprim with beta-cyclodextrin. , 2005, Journal of Pharmaceutical and Biomedical Analysis.

[11]  G. Becket,et al.  Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems. , 2004, Journal of pharmaceutical and biomedical analysis.

[12]  Hidekazu Ikezaki,et al.  Evaluation of the bitterness of antibiotics using a taste sensor , 2003, The Journal of pharmacy and pharmacology.

[13]  J. Manzanares,et al.  Ion-exchange fibers and drugs: a transient study. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[14]  S. Furlanetto,et al.  Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers. , 2002, Journal of pharmaceutical and biomedical analysis.

[15]  F. Podczeck,et al.  The Influence of Film Coating on Pellet Properties , 2002, Pharmaceutical development and technology.

[16]  J. Manzanares,et al.  Ion-exchange fibers and drugs: an equilibrium study. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[17]  E. Doelker,et al.  Taste masking as a consequence of the organisation of powder mixes. , 1999, Pharmaceutica Acta Helvetiae.

[18]  M. Nahata Pediatric Drug Formulations: Challenges and Potential Solutions , 1999, The Annals of pharmacotherapy.

[19]  Y. Yasoshima,et al.  Roles of chemical mediators in the taste system. , 1998, Japanese journal of pharmacology.

[20]  Joseph T. McDevitt,et al.  Accuracy of Tablet Splitting , 1998, Pharmacotherapy.

[21]  T. Hien An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[22]  J. Karbwang,et al.  Artemether in the treatment of multiple drug resistant falciparum malaria. , 1992, The Southeast Asian journal of tropical medicine and public health.

[23]  José Blanco-Méndez,et al.  Oral bioavailability of naproxen-β-cyclodextrin inclusion compound , 1991 .

[24]  P. Tyle,et al.  Effect of Size, Shape and Hardness of Particles in Suspension on Oral Palatability , 1990 .

[25]  S. Bafna,et al.  Cinchona alkaloids on ion-exchange resins. V. Ammonium form of resins. , 1973, Journal of Pharmacy and Science.

[26]  S. Borodkin,et al.  Interaction of amine drugs with a polycarboxylic acid ion-exchange resin. , 1970, Journal of pharmaceutical sciences.

[27]  T. Higuchi,et al.  Phase solubility techniques , 1965 .